摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

丙酰胺,N-[2-(4-吗啉基)-5-(1,4,5,6-四氢-4-甲基-6-羰基-3-哒嗪基)苯基]- | 103585-25-7

中文名称
丙酰胺,N-[2-(4-吗啉基)-5-(1,4,5,6-四氢-4-甲基-6-羰基-3-哒嗪基)苯基]-
中文别名
——
英文名称
6-(3-propionamido-4-morpholinophenyl)-5-methyl-4,5-dihydro-2H-pyridazine-3-one
英文别名
6-(4-Morpholino-3-propionylaminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;N-[5-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)-2-morpholin-4-ylphenyl]propanamide
丙酰胺,N-[2-(4-吗啉基)-5-(1,4,5,6-四氢-4-甲基-6-羰基-3-哒嗪基)苯基]-化学式
CAS
103585-25-7
化学式
C18H24N4O3
mdl
——
分子量
344.414
InChiKey
SXXHZYRUAPCLJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    83
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:7b249a5a35f29c78598fd2ee33784d61
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    α-morpholino-α-(4-morpholino-3-nitro-phenyl)-acetonitrile 在 palladium on activated charcoal 盐酸氢氧化钾氢气一水合肼溶剂黄146二异丙胺 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 25.0~100.0 ℃ 、303.98 kPa 条件下, 反应 76.67h, 生成 丙酰胺,N-[2-(4-吗啉基)-5-(1,4,5,6-四氢-4-甲基-6-羰基-3-哒嗪基)苯基]-
    参考文献:
    名称:
    6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics
    摘要:
    A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described. The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriovenous shunt in the rat. The synthesis and physical properties of the compounds are described. The structure-activity relationships reveal that non-aromatic nitrogen-containing heterocycles can confer high activity on the 6-phenyl-pyridazinone system, provided they are combined with an additional electron-withdrawing substituent in the phenyl ring. The most potent compounds (8i, 8b) had an ED(min) of 1-3 mg/kg after oral administration in the thrombus formation test.
    DOI:
    10.1016/0223-5234(91)90121-3
点击查看最新优质反应信息

文献信息

  • Alkyl substituted pyridazinones, processes for producing them, pharmaceutical preparations containing these compounds, and the use thereof
    申请人:CIBA-GEIGY AG
    公开号:EP0180542A2
    公开(公告)日:1986-05-07
    The present invention relates to novel 6-phenyl-5-alkyl substituted-4,5-dihydro-3-(2H)-pyridazinones of formula I: in which R, is halogen, lower alkyl, lower alkoxy, No2, NH2, NHCOR3 (R, is H or C1-C4 alkyl), CN, carboxy, lower alkoxycarbonyl, carbamoyl, CF3, or OH and R2 is C1-C4 alkyl; the tautomeric forms and salts thereof; as their racemic mixtures or as the individual optically-active forms. Compounds (I) are useful in pharmaceutical preparations having improved antithrombotic activity.
    本发明涉及式 I 的新型 6-苯基-5-烷基取代-4,5-二氢-3-(2H)-哒嗪酮:其中 R,是卤素、低级烷基、低级烷氧基、No2、NH2、NHCOR3(R,是 H 或 C1-C4烷基)、CN、羧基、低级烷氧基羰基、基甲酰基、CF3 或 OH,R2 是 C1-C4 烷基;其同分异构体及其盐;作为它们的外消旋混合物或作为单独的光学活性形式。 化合物 (I) 可用于提高抗血栓活性的药物制剂中。
  • US4629789A
    申请人:——
    公开号:US4629789A
    公开(公告)日:1986-12-16
  • US4699908A
    申请人:——
    公开号:US4699908A
    公开(公告)日:1987-10-13
查看更多